Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Neu-Laxova syndrome in which the cause of the disease is a mutation in the PHGDH gene.
Features include always present findings: Primary microcephaly, Brain atrophy, Enlarged brain ventricles (ventriculomegaly), and Short neck; and common findings: Long fingers, Cleft palate, Generalized edema, and Proptosis and others. 57 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 7 | Toe syndactyly, Long fingers, Radial deviation of finger |
Head and neck | 5 | Cleft palate, Primary microcephaly, Cleft upper lip |
Brain and nerves | 3 | Brain atrophy, Enlarged brain ventricles (ventriculomegaly), Depressed nasal ridge |
Skin | 2 | Yellow subcutaneous tissue covered by thin, scaly skin, Dry, scaly skin (ichthyosis) |
Muscles | 2 | Brain atrophy, Joint contracture of the hand |
Pregnancy and birth | 2 | Fetal akinesia sequence, Decreased fetal movement |
Eyes | 1 | Cataract |
Lungs and breathing | 1 | Pulmonary hypoplasia |
Heart and blood vessels | 1 | Ventricular septal defect |
Bones and joints | 1 | Joint contracture of the hand |
Growth and development | 1 | Intrauterine growth retardation |
Kidneys and urinary system | 1 | Renal agenesis |
Serine deficiency disorders include a spectrum of disease ranging from lethal prenatal-onset Neu-Laxova syndrome to adult-onset serine deficiency characterized by progressive polyneuropathy. Several clinical phenotypes can be identified: prenatal onset, infantile onset, juvenile onset, and adult onset. To date, more than 50 individuals have been identified with biallelic pathogenic variants in PHGDH, PSAT1, or PSPH [, , , , , , , , ]. The majority of individuals reported have the infantile-onset phenotype. The following description of the phenotypic features associated with this condition is based on these reports.
Neu-Laxova syndrome is characterized by severe intrauterine growth deficiency, decreased or absent fetal movements, microcephaly, congenital b...
Source: GeneReviews — "Serine Deficiency Disorders"
PHGDH function has not been fully characterized.
Neu-Laxova syndrome 1 is associated with mutations in the PHGDH gene on chromosome 1.
No consensus clinical diagnostic criteria for serine deficiency disorders have been published.
A serine deficiency disorder should be suspected in individuals with the following clinical, imaging, and laboratory findings and family history. Clinical and brain MRI findings can vary between phenotypes:
• Prenatal onset (Neu-Laxova syndrome)
Source: GeneReviews — "Serine Deficiency Disorders"
ASCT1 transporter deficiency, GOT2 deficiency, and other selected disorders with clinical and/or biochemical features that may resemble serine deficiency disorders are summarized in . Note: Given the first step in the synthesis of L-serine is an oxidation-reduction (redox) reaction , all defects that affect the redox reaction (e.g., GOT1 deficiency, mitochondrial complex I deficiency) can potentially affect the synthesis of serine and result in secondary serine deficiency. Table 2. Genetic Disorders in the Differential Diagnosis of Serine Deficiency Disorders
Gene | Disorder | MOI | Clinical Characteristics | Laboratory Findings |
|---|---|---|---|---|
SLC1A4 | ASCT1 transporter deficiency (OMIM 616657) |
Genetic testing for PHGDH is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Neu-Laxova syndrome 1 has been reported in the published literature.
No approved treatments are currently available for Neu-Laxova syndrome 1. The disease remains an area of unmet medical need.
No clinical practice guidelines for serine deficiency disorders have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with a serine deficiency disorder, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 3. Serine Deficiency Disorders: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment |
|---|---|---|
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education Neurobehavioral/ |
Psychiatric | Neuropsychiatric eval | For persons age 12 yrs: screening for behavior concerns incl sleep disturbances, ADHD, anxiety, /or findings suggestive of ASD Gastrointestinal/ |
Feeding | Gastroenterology/ nutrition/ feeding team eval | To incl eval of aspiration risk nutritional status; Consider eval for gastrostomy tube placement in persons w/dysphagia /or aspiration risk. |
Musculoskeletal | Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:; Gross motor fine motor skills; Contractures kyphoscoliosis; Mobility, ADL, need for adaptive devices; Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills) |
Eyes |
Source: GeneReviews — "Serine Deficiency Disorders"
Avoid known triggers of seizure activity (e.g., infection, physical stress, emotional stress).
Source: GeneReviews — "Serine Deficiency Disorders"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Serine Deficiency Disorders"
View trials for Neu-Laxova syndrome 1
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 5. Recommended Surveillance for Individuals with Serine Deficiency Disorders
System/Concern | Evaluation | Frequency |
|---|---|---|
Psychiatric | Behavioral assessment for anxiety, ADHD, ASD, aggression, or self-injury | At each visit in persons of school age Growth/Feeding |
Dental | Dental eval for risk of caries assoc w/oral L-serine powder | Every 6 mos |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; OT = occupational therapy; PT = physical therapy |
Source: GeneReviews — "Serine Deficiency Disorders"
Phenotype severity distribution: 4 always present features, 17 common features.
No clinical trials have been registered for Neu-Laxova syndrome 1.
5 publications have been identified in PubMed for Neu-Laxova syndrome 1. Research spans Case Report / Case Series (60%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).
Hao L (2026). [PMID: 41486146](https://pubmed.ncbi.nlm.nih.gov/41486146/). *J Biomed Sci*. [Review / Meta-Analysis]
Luo W (2026). [PMID: 41617352](https://pubmed.ncbi.nlm.nih.gov/41617352/). *Taiwan J Obstet Gynecol*. [Case Report / Case Series]
Whitcombe DD (2026). [PMID: 41885425](https://pubmed.ncbi.nlm.nih.gov/41885425/). *J Clin Neurophysiol*. [Diagnostic / Biomarker]
El-Dessouky SH (2025). [PMID: 39638571](https://pubmed.ncbi.nlm.nih.gov/39638571/). *Prenat Diagn*. [Case Report / Case Series]
Kong CW (2024). [PMID: 38807256](https://pubmed.ncbi.nlm.nih.gov/38807256/). *Hong Kong Med J*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 6:47 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Neu-Laxova syndrome 1
Considerable phenotypic overlap w/serine deficiency disorders. Assoc w/DD, microcephaly, spastic tetraplegia, variable seizures (infantile form may or may not be assoc w/seizures1). |
— |
GOT2 | GOT2 deficiency (OMIM 618721) | AR | Early-onset encephalopathy w/progressive microcephaly early-onset seizures (seizures are pyridoxine L-serine responsive).3; Atrophy white matter abnormalities w/thin corpus callosum on MRI | Inhibited synthesis of serine results in secondary serine deficiency.; In addition, citrulline may be ammonia lactate are mildly . |
ATP7A | Menkes disease (See ATP7A-Related Copper Transport Disorders.) | XL | Infants w/classic Menkes disease appear healthy until age 1.5-3 mos, when loss of developmental milestones, hypotonia, seizures, poor weight gain occur. Diagnosis is usually suspected when infants exhibit neurologic findings characteristic hair changes. | Low plasma CSF serine values were observed in multiple boys w/Menkes disease-related early-onset intractable seizures severe hypotonia (mechanism of low serine in these boys is unknown).2 |
~40 genes4 | Mitochondrial complex I deficiency (OMIM PS252010 500014) | Depends on genetic etiology | Severe DD seizures | Severe secondary serine deficiency has been observed in persons w/mitochondrial complex 1 deficiency.2 AR = autosomal recessive; CSF = cerebrospinal fluid; DD = developmental delay; MOI = mode of inheritance; XL = X-linked 1. 2. Authors, personal observations 3. 4. |
Source: GeneReviews — "Serine Deficiency Disorders"
Ophthalmologic eval |
To assess for nystagmus cataracts |
Genetic counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of serine deficiency disorders to facilitate medical personal decision making Family support resources |
Serine Deficiency Disorders: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other Epilepsy |